1. Hotez PJ, Brooker S, Bethony JM, Bottazzi ME, Loukas
A, Xiao S. Hookworm infection. N Engl J Med. 2004;351(8):799-807.
2. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D,
Savioli L. Soil-transmitted helminth infections: updating the global
picture. Trends Parasitol. 2003;19(12):547-551.
3. Chowdhury AB, Schad GA. Ancylostoma ceylanicum: a parasite
of man in Calcutta and environs. Am J Trop Med Hyg. 1972;21(3):300-301.
4. Walker NI, Croese J, Clouston AD, Parry M, Loukas A, Prociv
P. Eosinophilic enteritis in northeastern Australia. Pathology,
association with Ancylostoma caninum, and implications. Am
J Surg Pathol. 1995;19(3):328-337.
5. Jackson A, Heukelbach J, Calheiros CM, Soares Vde L, Harms
G, Feldmeier H. A study in a community in Brazil in which cutaneous
larva migrans is endemic. Clin Infect Dis. 2006;43(2):e13-e18.
6. Stoltzfus RJ, Chwaya HM, Tielsch JM, Schulze KJ, Albonico
M, Savioli L. Epidemiology of iron deficiency anemia in Zanzibari
schoolchildren: the importance of hookworms. Am J Clin Nutr. 1997;65(1):153-159.
7. Bethony J, Chen J, Lin S, et al. Emerging patterns of hookworm
infection: influence of aging on the intensity of Necator infection
in Hainan Province, People’s Republic of China. Clin Infect
Dis. 2002;35(11):1336-1344.
8. Williamson AL, Lecchi P, Turk BE, et al. A multi-enzyme cascade
of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J
Biol Chem. 2004;279(34):35950-35957.
9. Del Valle A, Jones BF, Harrison LM, Chadderdon RC, Cappello
M. Isolation and molecular cloning of a secreted hookworm platelet
inhibitor from adult Ancylostoma caninum. Mol
Biochem Parasitol. 2003;129(2):167-177.
10. Harrison LM, Nerlinger A, Bungiro RD, Cordova JL, Kuzmic
P, Cappello M. Molecular characterization of Ancylostoma inhibitors
of coagulation factor Xa. Hookworm anticoagulant activity in vitro
predicts parasite bloodfeeding in vivo. J Biol Chem. 2002;277(8):6223-6229.
11. Schad GA, Chowdhury AB, Dean CG, et al. Arrested development
in human hookworm infections: an adaptation to a seasonally unfavorable external
environment. Science. 1973;180(85): 52-54.
12. Yu SH, Jiang ZX, Xu LQ. Infantile hookworm disease in China.
A review. Acta Trop. 1995;59 (4):265-270.
13. Maxwell C, Hussain R, Nutman TB, et al. The clinical and
immunologic responses of normal human volunteers to low dose hookworm (Necator
americanus) infection. Am J Trop Med Hyg. 1987;37(1):126-134.
14. Crompton DW, Nesheim MC. Nutritional impact of intestinal
helminthiasis during the human life cycle.
Annu Rev Nutr. 2002;22:35-59.
[PubMed: 12055337]
15. Stephenson LS. Optimising the benefits of anthelmintic treatment
in children. Paediatr Drugs. 2001;3(7):495-508.
16. Prociv P, Croese J. Human eosinophilic enteritis caused
by dog hookworm Ancylostoma caninum. Lancet. 1990;335(8701):1299-1302.
17. Nutman TB, Ottesen EA, Ieng S, et al. Eosinophilia in Southeast
Asian refugees: evaluation at a referral center. J Infect
Dis. 1987;155(2):309-313.
18. Ochoa TJ, White AC Jr. Nitazoxanide for treatment of intestinal
parasites in children. Pediatr Infect Dis J. 2005;24(7):641-642.
19. Albonico M, Smith PG, Ercole E, et al. Rate of reinfection
with intestinal nematodes after treatment of children with mebendazole
or albendazole in a highly endemic area. Trans R Soc Trop Med
Hyg. 1995;89(5):538-541.
20. WHO. Report of the World Health Assembly. Resolution N.
54.19. 2001.
21. Albonico M, Engels D, Savioli L. Monitoring drug efficacy
and early detection of drug resistance in human soil-transmitted
nematodes: a pressing public health agenda for helminth control. Int
J Parasitol. 2004;34(11):1205-1210.
22. Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected
tropical diseases. N Engl J Med. 2007;357(10):1018-1027.
23. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs
S, Sachs JD. Incorporating a rapid-impact package for neglected
tropical diseases with programs for HIV/AIDS, tuberculosis,
and malaria. PLoS Med. 2006;3(5):e102.
24. Diemert DJ, Bethony JM, Hotez PJ. Hookworm vaccines. Clin
Infect Dis. 2008;46(2):282-288.